Physicians Interactive Advances Global Health Digital Engagement by Acquiring Univadis

Reading, Massachusetts (ots/PRNewswire) -

Authoritative Medical Content Platform Combined with Deep Digital
Expertise Offers Greater Opportunities to Engage Healthcare
Professionals and Improve Outcomes

Physicians Interactive [http://www.physiciansinteractive.com ](R)
(PI) announced today the launch of its recently acquired Univadis
[http://www.univadis.com ] platform, the world's largest healthcare
professional (HCP) network.

Univadis, previously a wholly-owned subsidiary of Merck (known as
MSD outside of the U.S. and Canada), has an active membership of more
than 3 million HCPs in over 20 languages, across 63 specialties and
in more than 90 countries. Univadis provides a comprehensive suite of
clinically relevant resources for HCPs, including medical news,
conference reports, references, textbooks and online education
modules.

The Univadis platform will now operate as part of Physicians
Interactive (a wholly-owned subsidiary of Merck, operating
independently from branded pharmaceutical and vaccine operations),
aligning with the company's suite of HCP-facing properties to deliver
a seamless engagement experience - both for HCP members seeking
credible medical content and for the life sciences companies, payors,
and providers who leverage these digital properties to drive
education and awareness of new medical and digital innovations aimed
at improving health outcomes.

"Adding Univadis to the Physicians Interactive brand underscores
our mission to advance health engagement across the entire spectrum,
as well as across the globe," said Donato Tramuto, Chairman and CEO
of Physicians Interactive. "There is a transformation underway in
healthcare, one that requires a fresh, integrated approach grounded
in proven digital strategies. With the expanded reach and rich
medical content this acquisition offers, we are even better
positioned to provide the end-to-end solutions our commercial
partners need to deeply engage healthcare professionals - resulting
in greater awareness and better health outcomes."

This acquisition also positions PI as a global digital partner for
its clients looking to further engage health care professionals
through digital channels - offering centrally managed, multinational
campaigns featuring localized content. Today these international
markets include France, Spain, Italy, the United Kingdom and the
United States; continued expansion into dozens of markets around the
world is planned over the next three years.

About Physicians Interactive

Physicians Interactive engages and empowers consumers and
healthcare professionals with instant access to content, solutions
and data to improve health outcomes. The company provides payors,
retailers and life science companies with sophisticated digital
engagement solutions to reach, message, educate and change behaviors.

Physicians Interactive is a wholly-owned subsidiary of Merck &
Co., Inc., Kenilworth, N.J., USA (known outside the U.S. and Canada
as MSD). With its own independent employees, editorial process,
business and financial operations, and governance, PI maintains its
information and the confidentiality of its customers' information
independent from its parent company. More information can be found at
http://www.PhysiciansInteractive.com.

About Merck

Merck is a global healthcare leader working to help the world be
well. Merck is known as MSD outside the United States and Canada.
Through our prescription medicines, vaccines, biologic therapies and
animal health products, we work with customers and operate in more
than 140 countries to deliver innovative health solutions. We also
demonstrate our commitment to increasing access to healthcare through
far-reaching policies, programs and partnerships. For more
information, visit http://www.merck.com and connect with us on
Twitter [https://twitter.com/Merck ], Facebook
[http://www.facebook.com/MerckBeWell ] and YouTube
[http://www.youtube.com/Merck ].

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J.,
USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the
"company") includes "forward-looking statements" within the meaning
of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These statements are based upon the
current beliefs and expectations of the company's management and are
subject to significant risks and uncertainties. If underlying
assumptions prove inaccurate or risks or uncertainties materialize,
actual results may differ materially from those set forth in the
forward-looking statements.

Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors,
including interest rate and currency exchange rate fluctuations; the
impact of pharmaceutical industry regulation and health care
legislation in the United States and internationally; global trends
toward health care cost containment; technological advances, new
products and patents attained by competitors; challenges inherent in
new product development, including obtaining regulatory approval; the
company's ability to accurately predict future market conditions;
manufacturing difficulties or delays; financial instability of
international economies and sovereign risk; dependence on the
effectiveness of the company's patents and other protections for
innovative products; and the exposure to litigation, including patent
litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Additional factors that could cause
results to differ materially from those described in the
forward-looking statements can be found in the company's 2014 Annual
Report on Form 10-K and the company's other filings with the
Securities and Exchange Commission (SEC) available at the SEC's
Internet site (http://www.sec.gov [http://cts.businesswire.com/ct/CT?
id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=50598462&lan=en-US&a
nchor=www.sec.gov&index=2&md5=b8b777d654167d19cdd7607ce6f9793f ] ).

Media Contact:
Physicians Interactive
media@PhysiciansInteractive.com

ots Originaltext: Physicians Interactive, Merck, Univadis
Im Internet recherchierbar: http://www.presseportal.de